Krawczyk, A., Strzałka-Mrozik, B., Juszczyk, K., Kimsa-Dudek, M., Wcisło-Dziadecka, D., & Gola, J. (2023). The MAP2K2 Gene as Potential Diagnostic Marker in Monitoring Adalimumab Therapy of Psoriatic Arthritis. Current pharmaceutical biotechnology, 24(2), 330. https://doi.org/10.2174/1389201023666220628111644
Chicago-Zitierstil (17. Ausg.)Krawczyk, Agata, Barbara Strzałka-Mrozik, Karol Juszczyk, Magdalena Kimsa-Dudek, Dominika Wcisło-Dziadecka, und Joanna Gola. "The MAP2K2 Gene as Potential Diagnostic Marker in Monitoring Adalimumab Therapy of Psoriatic Arthritis." Current Pharmaceutical Biotechnology 24, no. 2 (2023): 330. https://doi.org/10.2174/1389201023666220628111644.
MLA-Zitierstil (9. Ausg.)Krawczyk, Agata, et al. "The MAP2K2 Gene as Potential Diagnostic Marker in Monitoring Adalimumab Therapy of Psoriatic Arthritis." Current Pharmaceutical Biotechnology, vol. 24, no. 2, 2023, p. 330, https://doi.org/10.2174/1389201023666220628111644.